Eli Lilly

A $2.6 billion licensing and joint research deal with Eli Lilly boosted shares of South Korean biotech company…

Topline Novo Nordisk on Monday lowered the direct-to-consumer prices of its weight loss drug Wegovy and diabetes treatment…

Novo Nordisk is chopping prices again for its popular obesity treatment Wegovy, but doctors say the expense will…

Don’t look now, but the costs of America’s beloved weight loss drugs are about to come down. Way…

Last month, Eli Lilly’s weight-loss drug Mounjaro became India’s top-selling drug, overtaking GSK’s widely used antibiotic Augmentin. Mounjaro…

Eli Lilly’s GLP-1 drug is now the world’s best-selling drug. Novo Nordisk is struggling with declining market share.…

Healthcare stocks are hot right now. Several factors are driving them higher, including innovations in areas like heart…

Eli Lilly has been investing in radiopharmaceuticals, which can help revolutionize cancer care in the future. Its early…

New Delhi: Maintaining its growth momentum for the seventh straight month, Eli Lilly’s type-2 diabetes and weight-loss drug…

The cost of some of the most widely used weight loss medications in the United States is set…

Eli Lilly’s GLP-1 drug portfolio should power the business for at least the next decade. But the market…

Consumers will soon be able to pick up single-dose vials of the weight loss drug Zepbound at Walmart…

Deal With Eli Lilly Propels Founder Of Korean Biotech Firm Into Billionaire Ranks